Procavea

Procavea has developed a first-class protein-based delivery platform for RNA therapy, which is characterized by ease of manufacturing and engineering. It has the potential to break the deadlock where current drug delivery methods are considered the biggest challenge limiting the development of siRNA therapy. The advantages of Procavea's protein cages include being non-toxic, biodegradable, compatible with various cargoes, and capable of targeting specific cell types.